In Hydra, head regeneration and bud formation appear to be very similar processes. The fact that there are genes whose expression is specific for one of the two processes suggests that they do not have identical molecular bases. We analyzed the signal transduction pathways regulating bud development using inhibitors of protein kinase C, Src, PI3K and ERK. The four inhibitors reversibly blocked bud formation in Hydra when applied before stage 1. Once the bud reached stage 3, three of them had no effect and the bud developed normally. The inhibitors blocked the expression of Budhead, an early head marker, and of CnOtx which are specific for bud formation. The results are in agreement with the central role of a signaling pathway mediated by Src on bud development. q
Introduction
In Hydra, a head can form in four different circumstances. It forms de novo during embryogenesis and bud formation, the animal's asexual form of reproduction. Following bisection anywhere along the body column, a head will regenerate at the apical end of the lower piece. Resulting from the tissue dynamics of the adult organism (Campbell, 1967a,b; David and Campbell, 1972) , tissue is constantly displaced from the body column into the head requiring continual remodeling of body column tissue into head tissue.
An important issue is how similar or how different are the molecular processes underlying head formation in each of these conditions. The patterning processes underlying head formation are well understood at a tissue and cell level during head regeneration, bud formation and maintenance of the pattern in the context of the tissue dynamics. The organizer region of the head sends out a pair of signals, one of which sets up a gradient of head formation capacity along the body column while the other inhibits head formation in the body column. A second organizer region in the foot has similar capacities. These organizers and gradients control axial patterning along the column (MacWilliams, 1983a,b; Bode and Bode, 1984; Schiliro et al., 1999; Broun and Bode, 2002) .
Some information about the molecular basis of head formation and axis formation has been gained by the characterization of several transcription factors that are expressed in the adult head. They are also expressed during bud formation as well as during head regeneration. In addition, temporally they appear in the same order. Three of them, HyBra1, Budhead, and Cngsc are expressed in the hypostome and they appear in the same temporal order during both head regeneration and bud formation (Technau and Bode, 1999; Martinez et al., 1997; Broun et al., 1999) . However, there are differences between head regeneration and head formation during budding. Cnotx and Cnmsx, the hydra members of the otx and msx families, are expressed during bud formation, but not during head regeneration (Smith et al., 1999; McCord et al., in preparation) . Further, they are expressed only at a very early stage during budding. This indicates that there are differences between the two modes of head formation, and that the differences occur at the initiation of the head formation in the two processes.
In addition, some of the signal transduction pathways involved in head formation have been elucidated. A transduction system mediated by Protein Kinase C (PKC) has been implicated for head regeneration. Treating animals with PKC activators, such as diacylglycerol (DAG), 12-Otetradecanoylphorbol-13-acetate (TPA) and arachidonic acid results in the formation of ectopic heads (Müller, 1989 (Müller, , 1990 Müller et al., 1993) . Treatment with sphingosine, the natural inhibitor of PKC, and two other inhibitors, staurosporine and H7, block head regeneration (Cardenas et al., 2000) . The activation of PKC by TPA produces an enhanced transcription of ks1, a head specific gene (Weinziger et al., 1994; Endl et al., 1999) and inhibition by sphingosine resulted in inhibition of the transcription of the same gene (Cardenas et al., 2000) . We have also found that selective Src kinase inhibitors, PP1/AGL1872 and PP2/AG1879, inhibited head regeneration and the expression of the head specific genes ks1, Hybra1 and Hym301 (Cardenas et al., 2000) . These results suggest that another pathway mediated by Src could also be involved in head regeneration.
To determine if head formation during budding made use of a similar set of signal transduction pathways, a set of specific kinase inhibitors was employed. Using morphological and gene expression assays, we found that the signaling pathways mediated by Src, and PI3K plays a central regulatory role in bud formation.
Results

Bud formation
Bud formation occurs in the budding zone, about twothirds of the distance down the body column. The initial step is the formation of a circular placode in the budding zone, which subsequently evaginates and then elongates into cylindrical protrusion (see Fig. 1 ). Since stage 1, it is possible to identify the tissue that will form the head (light gray in the center of the new bud), the body column and the foot (dark gray circle). Bud tissue comes mainly from the recruitment of concentric tissue of parental tissue adjacent to the developing bud. Thereafter, the head forms at the distal end of the protrusion as indicated by the appearance of tentacles and the hypostome. Subsequently, a foot forms at the proximal end. Finally, the bud detaches from the parent and when fed will develop into an adult in 4-6 days. The mechanism by which bud formation is controlled is not well understood. It is generally assumed that head formation, during budding and head regeneration, is regulated by the same molecular mechanisms.
Inhibition experiments
There are differences between head regeneration and head formation during budding. As mentioned previously, the genes Hybra1, Budhead and Cngsc are expressed temporally in the same order during the two processes (Technau and Bode, 1999; Martinez et al., 1997; Broun et al., 1999) . In contrast, Cnotx and Cnmsx are expressed at a very early stage during budding, but they are not expressed during head regeneration (Smith et al., 1999; McCord et al., in preparation) . This indicates that one distinction between the two modes of head formation occurs at the initiation of the two processes. Albeit it is clear that the PKC and Src signal transduction pathways are critical for head regeneration, it is not known whether they are necessary for head formation during budding (Müller, 1996; Cardenas et al., 2000) . To gain some insight into the signal transduction pathway(s) involved in the budding process, we have used specific inhibitors for several kinases. Initially, we tested if inhibitors against these two enzymes, PP2/AG1879 for Src and Sphingosine for PKC, could inhibit bud formation.
Earlier, we used PP1/AGL 1872 to inhibit Src activity (Cardenas et al., 2000) , and subsequently have shown that PP1 and PP2 have the same effect (data not shown). PP2 was used for the experiments described here. Freshly detached buds were cultured for 24 h, exposed to the inhibitor for the next 72 h, and then returned to hydra medium. PP2/AG 1879 effectively blocked bud initiation ( Fig. 2A) , although the effect was reversible. Twenty-four hours after removal of the inhibitor 10% of the animals were forming buds ( Fig.  2A) , and by 96 h almost 100% of the animals developed a bud (data not shown). In contrast, sphingosine did not block bud initiation (Fig. 2B) . The results suggest that the Src pathway, but not the PKC pathway, is necessary for bud initiation. Staurosporine, a less specific PKC inhibitor, could inhibit budding (Fig. 2C ), but the animals remained inhibited for several days more (compared with the effect of PP2 where the animals began to bud 24 h after the elimination of the inhibitor) and then began to bud 5 days after the inhibitor was washed. The effect of staurosporine could suggest the participation of other kinases, either in the same pathway mediated by Src or in another.
The effects of two other inhibitors were also examined. Apigenin, an ERK inhibitor, was tested as it is a common point for the signal transduction pathways mediated by PKC and Src. Treatment with LY294002, an inhibitor of PI3K, was also carried out as there are reports indicating that forkhead genes are regulated by the P13K-PKB pathway (Brownawell et al., 2001; Kops et al., 1999; Brunet at al., 1999) . Budhead, a hydra forkhead homologue is expressed early during bud formation (Martinez et al., 1997) . As shown in Fig. 3 , apigenin ( Fig. 3A) and LY294002 ( Fig.  3B ) could inhibit bud initiation. The inhibitors against the three kinases, Src, ERK and PI3K, blocked bud initiation completely during the period of treatment (72 h), and for at least an additional 24 h more after removing the inhibitors. The effect of LY294002 must be more complex because it blocked bud initiation for 72 h more after removal of the inhibitor (Fig. 3B) . Thereafter, the budding process reassumes.
The observed effects are not resulting from toxic effects for any of the inhibitors examined. Foot regeneration is not affected; the animals regenerated it in the presence of any of the inhibitors tested. Another evidence came from their effect on the cell cycle. PP2 did not inhibit the incorporation of BrdU to the DNA, but apigenine and LY294002 could inhibit up to 50% its incorporation in certain types of cells (Cardenas et al., 2000; Manuel et al., in preparation) .
Src is required for budding initiation
To determine when during bud development the activity of the Src kinase was required, PP2/AG1879 was added at different stages of bud development. Using the bud stages described by Otto and Campbell (1977) , animals at three stages of bud development were examined. These animals were decapitated to enhance the fraction of animals forming buds. Animals were decapitated right below the tentacle ring and incubated in hydra medium plus PP2/AG1879 for 3 days, replacing the inhibitor every 24 h.
Non-budding animals (stage 0 buds; Fig. 4A ) treated with PP2/AG1879 did not form buds (Fig. 4D) , while 60% of the controls did during the 3d incubation period. In contrast, animals in which the bud was a cylindrical protrusion (stage 3-5 buds; Fig. 4B ) continued to develop forming a complete head. However, they did not form feet and did not detach from the parental polyp (Fig. 4E) . Nor did the adult regenerate a head (Fig. 4E) , which was expected since blocking Src kinase is known to block head regeneration (Cardenas et al., 2000) . All the control animals completed bud formation with subsequent detachment of the young polyps. Animals with buds that had developed a head (stage 6-9 buds; Fig. 4C ) at the beginning of inhibitor treatment exhibited two different behaviors: 60% of them did not form a foot (Fig. 4F) , analogous to the animals treated from stage 3 to 5. The remaining 40% of the animals formed feet and detached from the parent, but no new buds were developed during the 6-8 days of the experiment.
The inhibitory effect of PP2/AG1879 on foot formation during budding was specific for bud formation, as it did not occur during foot regeneration. Treated animals, bisected at any point from the middle of the body column to the upper end of the peduncle always developed a foot (Cardenas et al., 2000 ; data not shown). The same type of experiment was carried out with non-decapitated animals, and the results were basically the same (data not shown). Fig. 2 . Effect of the inhibition of Src and PKC on budding. Freshly detached polyps (24 h old) were treated with (A) 1 mM PP2/AG1879, (B) 2 mM sphingosine or (C) 12 nM staurosporine. Controls are indicated by circles and inhibitor-treated animals by squares. The arrows indicate the days when the inhibitors were added (day 1) and removed (day 4). Each value is the average^SD of three experiments. Ten animals were used for each experiment.
To determine if the other inhibitors had the same effect on the foot formation during budding, animals with stage 3-5 buds were treated with PP2/AG1879, apigenin and LY294002. Foot formation was assayed in terms of the capacity of buds to detach from the parent. As neither apigenin nor LY294002 inhibited foot formation (Fig. 5B,  C) , only PP2/AG1879 (Fig. 5A ) of this set of kinase inhibitors is capable of inhibiting foot formation. Staurosporine was tested and it had no effect (data not shown). This result suggests that of the three kinases only Src has an important role in the signaling pathway leading to foot formation de novo.
Gene expression during budding
Three of the kinase inhibitors blocked bud formation at an early stage before any visible signs of budding had occurred. As a second measure of the effect of the inhibitors, we examined two genes that are expressed very early during bud formation. Cnotx, the hydra otx homologue, is specifically expressed during early stages of bud formation appearing initially just as visible bud formation begins (Smith et al., 1999) . Budhead is a hydra forkhead homologue, which is a head specific gene that appears before bud placode formation (stage 1) as a small spot that is future distal tip of the developing bud (Martinez et al., 1997) .
The effect of three inhibitors (PP2/AG1879, apigenin and LY294002) on the expression of these two genes was examined with in situ hybridization. The 24 and 48 h old detached buds were exposed to one of the three inhibitors for 48 h. In Fig. 6 , we show the results of the animals treated with PP2/AG1879. Control animals begin to produce new buds (Fig. 6A, C) , evidenced as a dark spot, while inhibitortreated animals did not. Bud spots were also found on the control animals, without any previous bud, for both genes (Fig. 6E, G) , while no bud spots were found on any of the inhibitor-treated animals (Fig. 6B, D, F, H ). All the animals Fig. 3 . Effect of the inhibition of ERK1-2 and PI3K on budding. Freshly detached polyps (24 h old) were treated with (A) 4 mM apigenin or (B) 6 mM LY294002. Controls are indicated by circles and inhibitor-treated animals by squares. The arrows indicate the days when the inhibitors were added (day 1) and removed (day 4). Each value is the average^SD of three experiments. Ten animals were used for each experiment. Analogous results were obtained for the other two inhibitors (data not shown). In addition, PP2/AG1879 could block the expression of two other genes, Hybra1 and Cnmsx, which are also expressed at early stages (Stage 0-1) of bud development (results not shown). Thus, the effect of the inhibitors on bud initiation correlates directly with their inhibition of the expression of early bud genes. The three inhibitors appear to block bud formation at very early stages of the process.
Discussion
Similarities and differences in the several forms of head formation
A head forms in hydra in several situations. It forms during embryogenesis as well as during bud formation. After bisection of the body column, a head will regenerate at the apical end of the lower half. In aggregates, heads form de novo from a spherical shell of unpatterned tissue. And, less obviously is the continuous formation in the context of the tissue dynamics of the adult animal. The head is in a steady state of continuously generating new tissue and losing existing tissue. In the latter case, the signaling processes controlling head patterning are constantly active to maintain the right pattern.
Head formation during head regeneration and bud formation appear to be very similar processes. Both processes require the recruitment of adjacent tissue to form a head and to establish the anterior-posterior pattern. Most of the head specific genes cloned to date are expressed in the same order and are analogous in the two situations. For example, HyBra1, Budhead and HyWnt are expressed in the hypostome (Technau and Bode, 1999; Martinez et al., 1997; Hobmayer et al., 2000) . Cngsc is expressed at the border between the hypostome and the tentacle zone (Broun et al., 1999) , ks1 in the tentacles and the tentacle zone (Weinziger et al., 1994; Endl et al., 1999) , HyAlx at the tentacle/tentacle zone border (Smith at al., 2000) and Hym-301 in the tentacle zone and the apical end of the body column (Takahashi et al., in preparation) . This group of genes is expressed in the same order, both in head regeneration and in bud formation. Further, the set is expressed in the same locations in the adult head as part of maintaining the head in a steady state. In addition, there are genes that are expressed in one or two, but not all the three types of head formation. Heady, encoding a peptide, is expressed in early stages of head regeneration and bud formation, but not in the adult (Lohmann and Bosch, 2000) . Cnotx (Smith et al., 1999) and Cnmsx (McCord et al., in preparation) are expressed during very early stages of bud formation, but not during head regeneration or in the adult head.
These results demonstrate that although head regeneration and budding seem to be analogous processes, some differences exist. Most likely they occur at early steps in the head formation process. Plausibly they reflect differences in the signaling systems required to maintain or rees- tablish the pattern (as in the adult head or during head regeneration), and those necessary for the initiation of a new axis (bud formation). This would account for the expression of Cnotx and Cnmsx exclusively during bud formation. Once the new axis is established, the head develops in the same way. This is reflected in the observation that the genes are the same, and they are expressed in the same order in the three situations.
Some information is available concerning the processes regulating the initiation of bud formation at a tissue level. Following detachment from the parent, a mature bud when fed daily will begin to form a bud within 3-4 days as indicated by the evagination of a small, conical evagination. However, the bud formation process begins at least 1 day earlier, because the bud-specific genes, Cnmsx and Cnotx, appear by 3 days after detachment, and they are active only during early stages of bud formation, but not at all during head regeneration (Smith et al., 1999; McCord et al., in preparation) . Transplantation experiments indicated that immediately after a bud begins to evaginate (Stage 2-3, Fig. 1 ), the distal end of the bud is committed to head formation (Li and Yao, 1945; Sanyal, 1966) . Hence, commitment to head formation occurs very early during bud formation. Subsequently, the head activator, a peptide, which is known to accelerate head regeneration (Schaller et al., 1990 ) also accelerates bud formation (Hobmayer et al., 1997) indicating that it has a role in this process. Finally, commitment to foot formation occurs to foot formation occurs later when the bud has reached the stage of a cylindrical protrusion (Li and Yao, 1945) .
Signal transduction pathways affecting head formation
Some information concerning the signal transduction pathways affecting head formation during head regeneration has been described previously. Using both activators and inhibitors, it is clear that the signal transduction pathways mediated by PKC and Src play a central role in head regeneration (Müller, 1996; Cardenas et al., 2000) . The two pathways play different roles as the one mediated by PKC regulates proliferation while the one mediated by Src affects differentiation (Cardenas et al., 2000) . Recent results obtained with RNAi using Src dsRNA also indicate a role for Src in head regeneration (Cardenas and Salgado, in preparation) .
Here, we have provided evidence for the central role of the non-receptor tyrosine kinase, Src, during bud formation. Using the Src-specific inhibitor, PP2/AG1879, the initiation of bud formation was inhibited. However, once a bud has reached stage 3-5, head formation was no longer affected although foot formation was blocked. Since commitment to foot formation occurs most likely after stage 3-4 is reached, these results show that Src is required for the initiation of both head and foot formation during budding. Interestingly, Src did not block foot regeneration in a bisected body column indicating that the initiation of foot formation also involves an initial process that is different from foot regeneration. Thus, Src is required for head regeneration as well for the initiation of head and foot formation during budding.
In contrast, PKC, which appears to have two functions during head regeneration (regulating proliferation and differentiation), does not have any important regulatory role during budding. Sphingosine, a specific inhibitor of PKC, did not block either bud initiation or the subsequent development of the bud. During head regeneration, this inhibitor can specifically inhibit the process as well the expression of some early genes (Cardenas et al., 2000) . However, here we cannot conclude that PKC has no regulatory role during bud formation since the metabolic conditions of the animals for regeneration and budding are different. For regeneration studies the animals are not fed for 5 days. They are starved 48 h before the experiments, and they cannot take up food at least for 72 h post-decapitation. In contrast, the budding process is completely dependent on tissue growth that occurs only when animals are well fed; starved animals do not develop buds. This distinc- tion could explain why sphingosine did not inhibit bud formation.
In this regard, it is of interest that staurosporine, a less specific inhibitor for PKC, has a strong inhibitory effect on bud initiation. Its effect could be explained by its capacity to inhibit other kinases which may be involved in bud initiation, or because it is not metabolized (a distinction with sphingosine) so that its inhibitory effect on PKC is more robust.
The inhibition of ERK by apigenin blocks bud initiation. This result was expected since the MAPK pathway, and specifically ERK1-2, are a common point where different signaling pathways converge. For head regeneration this appears to be the signaling pathway leading through Src, continuing through Ras to MAPK. Since the gene ras2 is up regulated during head regeneration in hydra (Bosch et al., 1995) , one would expect this same signal pathway to be active during head development during bud formation. However, Src appears to be acting through another pathway for foot formation during budding. This is supported by the fact that the inhibition of Src, but not the inhibition of ERK1-2 blocks foot formation before stage 6 of budding. An analysis of more foot specific genes should lead to an understanding of which signaling system is involved. Finally, it should be noted PP2/AG1879 can inhibit foot development only during budding, but not during foot regeneration. This finding is consistent with the idea that the main differences between budding and regeneration are at the beginning of the process, and basically with the formation of a new axis.
As mentioned previously, one early gene involved in head formation, both during budding and head regeneration, is Budhead, a member of the forkhead family of transcription factors (Martinez et al., 1997 ). An increasing body of evidence indicates that this family of genes is regulated by the signaling pathway mediated by PI3K-PKB during proliferation and development (Brownawell et al., 2001; Kops et al., 1999; Brunet et al., 1999) . In addition, there is evidence for a second signal transduction pathway leading to MAPK that affects developmental processes (Carballada et al., 2001) . In agreement with these observations, the specific inhibitor of the PI3K, LY294002, could inhibit the initiation of bud formation, but once started, it did not inhibit the further development of a bud. The specificity for the inhibition of the initial stages of budding removes the possibility of a more general toxic effect on the animals and points to the specific inhibition of the developmental process. The strong inhibitory effect of LY294002 on budding could be resulting from the central role of PI3K regulating proliferation, differentiation and apoptosis. During head regeneration, it inhibits specifically head formation and the expression of several early genes like ks1, Hybra, Budhead and Axl (Manuel et al., in preparation). Here, we have shown that it inhibits bud formation most likely by preventing cell proliferation (A. Aguilera, unpublished results), which is necessary for the development of a bud. The main inhibitory effect of LY294002 probably happens during the early steps of patterning and differentiation, but we cannot rule out that the inhibition of the proliferation has an important role also.
To summarize, the three inhibitors, PP2/AG1879, LY294002 and apigenin, which inhibit Src, PI3K and ERK prevent the initiation of bud formation. This indicates that signal transduction pathways involving each of these enzymes are required for bud initiation. Inhibition of two genes expressed early during bud formation, Budhead and Cnotx, provides additional evidence for PI3K and ERK. For Src, the inhibition of these two genes plus the inhibition of HyBra1 and Cnmsx during early stages of bud formation supports this conclusion. Src has an additional role not shared by PI3K an ERK in that once bud formation is underway it has a role in foot formation in the developing bud.
Experimental procedures
Animals
Hydra magnipapillata (wt strain 105) was used for all experiments. Animals were cultured using standard procedures (Takano and Sugiyama, 1983) and were fed daily.
Inhibition experiments
1. Collection of animals of different ages. Freshly dropped buds were collected to obtain groups of animals of different ages. Groups A, B, C and D were collected at 0, 24, 48 and 72 h, respectively. The effect of an inhibitor on bud formation was determined by examining animals daily with a dissecting microscope for the next 7 days. All groups were fed daily. 2. Exposure to inhibitors. Ten 24 h old dropped buds were incubated in hydra medium at 188C, and at a density of 1-2 polyps/ml. They were exposed to an inhibitor for 3 days, which was replaced daily. The inhibitors used were PP2/AG1879 (1 mM), apigenin (4 mM), LY294002 (6 mM), sphingosine (2 mM) and staurosporine (12 nM). Control animals were incubated in hydra medium plus the solvent in which the inhibitors were dissolved [dimethyl sulfoxide (DMSO), ethanol]. Animal density was 1-2 polyps/ml and budding was followed microscopically. PP2/AG1879, apigenin and LY294002 were obtained from Calbiochem, and sphingosine and staurosporine from Sigma.
In situ hybridization
In situ hybridization was carried out on samples of control and inhibitor-treated 24, 48 and 72 h old dropped buds. The animals of each sample were relaxed in a 2% urethane solution and fixed in 4% paraformaldehyde. The expression patterns of Cnotx and Budhead were determined using the whole-mount in situ hybridization procedure described previously (Grens et al., 1996) .
